Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details

Chart Of The Day: Moderna Set For Explosive Move (But Not Yet Clear Which Way)

By Investing.com (Pinchas Cohen/Investing.com)Stock MarketsJan 20, 2021 15:47
ng.investing.com/analysis/chart-of-the-day-moderna-set-for-explosive-move-but-not-yet-clear-which-way-49918
Chart Of The Day: Moderna Set For Explosive Move (But Not Yet Clear Which Way)
By Investing.com (Pinchas Cohen/Investing.com)   |  Jan 20, 2021 15:47
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Saying that Moderna (NASDAQ:MRNA) was the best performing COVID-19 vaccine stock in the past year would be a laughable understatement. Shares of  AstraZeneca (NASDAQ:AZN) gained 0.25% for the period; Pfizer (NYSE:PFE) added 3.1% of value. But Moderna blew past all of them, rising 687%.

Yesterday, we noted that Pfizer’s technical chart suggests a selloff could be in the cards. Today we'll be providing both bullish and bearish setups for Moderna since the biotech stock has reached an inflection point based on its technicals.

But perhaps the key fundamental question is why Moderna shares have so overwhelmingly outperformed the competition?

The efficacy numbers tell the story. Moderna's vaccine demonstrated 95% effectiveness in prevention of coronavirus and was 100% effective when used to combat severe cases of the virus.

Based on those results, 30 countries approved the use of Moderna's vaccine. The Cambridge, Massachusetts-based company has already earned $2.89 billion and is expected to receive another $11.7 billion this year from this vaccine alone. But that’s only the beginning.

The biotech is now running clinical trials in order to expand the use of its vaccine to young children and adolescents. It's also testing a booster shot for adults, with which to extend the efficacy of the immunization. If successful, this could also mean additional, guaranteed revenue on an annual basis.

MRNA Daily
MRNA Daily

The stock has been trading within a rising channel since May, but broke through the channel top in November, after which it reached an all-time high of $178.50 on Dec. 1.

Moderna then corrected, losing 42.5% over the course of the month, till Dec. 31. The drop sent the price below the channel top on Dec. 28. Then the stock managed to pierce the channel top a second time, on Jan. 12, climbing once again until Jan. 15. Yesterday, the stock dipped, but found support at the top of the previous channel.

The obvious question of course is what happens next? While, we don't know, we can at least navigate probabilities.

On its face, this pattern appears to support the view that the new, steeper rising channel is intact, providing a buying opportunity, with the expectation the price will bounce off the bottom of the new (green) channel, to retest its all-time high, as it resumes moving along the rising channel’s trajectory.

However, the congested range in which the price rose 21% just this month is a cause for concern. It could be a developing rising flag, bearish after the preceding 40+% plunge in exactly one month. The diminishing volume amid the price advance increases the possibility of that scenario.

But the flag’s location is also significant. It developed at the crossroads of the former channel top, the foot of the potential new channel bottom at the 50 DMA and it meets the downtrend line from the December record high. All this signifies that the price has reached a focal point, and is set for an explosive move.

While the lagging MACD is still in a bullish cross since this month’s rebound, the sensitive RSI is retesting its uptrend line after falling below it and climbing back above it. In other words, momentum, too, is on the edge of a knife, much like the price is in the eye of the storm.

A downside flag breakout would demonstrate a continued decline from the Dec. 1 all-time high, to retest the original channel bottom at $80. If the price breaks through the downtrend line (dotted red), and preferably through the flag top, the odds would increase of it retesting the record.

Trading Strategies

Conservative Short: wait for second trough to establish a downtrend, followed by a return move.

Conservative Long: wait for breakout above the downtrend line, followed by a dip that demonstrates support.

Moderate Short: wait for a 3% (preferably, including a weekend), 3-day downside penetration, followed by a return move.

Moderate Long: wait for a breakout above the downtrend line.

Aggressive Short: wait for a 2% downside breakout, followed by return-move, demonstrating resistance.

Aggressive Long: buy now, provided you understand and accept the risk and prepare with a coherent trade plan.

Here’s just an example:

Trade Sample – Aggressive Long

  • Entry: $124
  • Stop-Loss: $119
  • Risk: $5
  • Target: $174
  • Reward: $50
  • Risk:Reward Ratio: 1:10
Chart Of The Day: Moderna Set For Explosive Move (But Not Yet Clear Which Way)
 

Related Articles

Chart Of The Day: Moderna Set For Explosive Move (But Not Yet Clear Which Way)

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email